Publication at Central Library of Charles University |
1999
Abstract
Exogenous Sufractant has been to treatment of immature lungs of premature babies for more than 30 years. Recently its profits has been shown in the treatment of socondary deficit
Exogenous Sufractant has been to treatment of immature lungs of premature babies for more than 30 years. Recently its profits has been shown in the treatment of socondary deficit